Scrambler Therapy With Duloxetine-based Usual Care vs Duloxetine-based Usual Care for Chemotherapy-induced Peripheral Neuropathy.

Clinical trial NCT06914557 · RECRUITING

Trial details

NCT number: NCT06914557
Sponsor: Fox Chase Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

CIPN - Chemotherapy-Induced Peripheral Neuropathy Pain

Start date: 2025-03-03
Primary completion: 2027-03-30
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.